Price J T, Bonovich M T, Kohn E C
Molecular Signaling Section, National Cancer Institute, Bethesda, Maryland, USA.
Crit Rev Biochem Mol Biol. 1997;32(3):175-253. doi: 10.3109/10409239709082573.
The progression of a tumor cell from one of benign delimited proliferation to invasive and metastatic growth is the major cause of poor clinical outcome of cancer patients. Recent research has revealed that this complex process requires many components for successful dissemination and growth of the tumor cell at secondary sites. These include angiogenesis, enhanced extracellular matrix degradation via tumor and host-secreted proteases, tumor cell migration, and modulation of tumor cell adhesion. Each individual component is multifaceted and is discussed within this review with respect to historical and recent findings. The identification of components and their interrelationship have yielded new therapeutic targets leading to the development of agents that may prove effective in the treatment of cancer and its metastatic progression.
肿瘤细胞从良性局限性增殖发展为侵袭性和转移性生长是癌症患者临床预后不良的主要原因。最近的研究表明,这一复杂过程需要许多成分才能使肿瘤细胞在继发部位成功扩散和生长。这些成分包括血管生成、通过肿瘤和宿主分泌的蛋白酶增强细胞外基质降解、肿瘤细胞迁移以及肿瘤细胞黏附的调节。每个单独的成分都具有多面性,本文将根据历史和最新研究结果对其进行讨论。对这些成分及其相互关系的识别产生了新的治疗靶点,从而推动了可能在癌症及其转移进展治疗中有效的药物的开发。